Equasens: 2024 nine-month revenue: €158.2 million - Return to growth in Q3 (+0.3%)

Villers-lès-Nancy, 7 November 2024 - 6:00 p.m. (CET)PRESS RELEASE 2024 nine-month revenue: €158.2 million                 Return to growth in Q3 (+0.3%)Revenue (€m)2023 Reported basis2024 Reported basisChange / Reported basis- Ségur 2024+Ségur 2023- External Growth Change / Like-for-like basisQ156.253.3-2.9-5.2%0.31.42.0-3.8-6.7%Q256.454.7-1.7-3.0%0.31.21.7-2...

Villers Les Nancy, 07/11/2024 (informazione.it - comunicati stampa - information technology)

Villers-lès-Nancy, 7 November 2024 - 6:00 p.m. (CET)

PRESS RELEASE

2024 nine-month revenue: €158.2 million
                

Return to growth in Q3 (+0.3%)

At September 30, 2024, Equasens Group reported year-to-date revenue of €158.2m, down 2.8% on a reported basis from one year earlier and 4.9% like-for-like.

Operating highlights:

This Division accounts for 75.9% of total revenue.

This Division accounts for 14.3% of total revenue.

  

This Division accounts for 5.2% of total revenue.

The Division accounts for 3.6% of total revenue.

2024 outlook

Financial calendar:

About Group Equasens

With more than 1,300 employees, Equasens Group is today a key player in the European healthcare sector, providing software and hardware solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, hospital-at-home programmes, retirement homes, health centres) in both primary and secondary care sectors.

With operations in in France, Germany, Great Britain, Belgium, Ireland, Italy, and Luxembourg, Equasens Group today brings together healthcare professionals within a unique ecosystem in France and Europe benefiting people by making available the very best of technology.

Listed on Euronext Paris™ - Compartment B

Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC SMALL and CAC All-Tradable
Included in the Euronext Tech Leaders segment and the European Rising Tech label

Eligible for the Deferred Settlement Service (“Service à Règlement Différé” - SRD) and equity savings accounts invested in small and mid-caps (PEA-PME).
ISIN: FR 0012882389 – Ticker Code: EQS

Get all the news about Equasens Group www.equasens.com and on LinkedIn

CONTACTS

Analyst and Investor Relations:
Chief Administrative and Financial Officer: Frédérique Schmidt
Tel: +33 (0)3 83 15 90 67 - frederique.schmidt@equasens.com

Financial communications agency:
FIN'EXTENSO - Isabelle Aprile

Tel.: +33 (0)6 17 38 61 78 - i.aprile@finextenso.fr

Attachment